Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACURA PHARMACEUTICALS, INC | 15,000 | reported | 02 Jan 2013 | tx 16+90,000−111,689 |
| Anacor Pharmaceuticals Inc | 15,000 | reported | 25 May 2011 | tx 8+1,603,104−1,558,104 |
| Vaxart, Inc. | 9,000 | reported | 12 Jun 2019 | tx 3+30,815,370 |
| NephroGenex, Inc. | 6,870 | reported | 30 Apr 2015 | tx 10+10,037,005−19,750,360 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2019 | GRANT_AWARD | Vaxart, Inc. | 12,700 | 0.00 USD | deriv |
| 12 Jun 2019 | GRANT_AWARD | Vaxart, Inc. | 9,000 | 0.00 USD | deriv |
| 13 Feb 2018 | GRANT_AWARD | Vaxart, Inc. | 30,793,670 | — | |
| 30 Apr 2015 | GRANT_AWARD | NephroGenex, Inc. | 6,870 | 0.00 USD | deriv |
| 15 May 2014 | GRANT_AWARD | NephroGenex, Inc. | 3,076 | 0.00 USD | deriv |
| 14 Feb 2014 | CONVERSION | NephroGenex, Inc. | 2,148,365 | — | |
| 14 Feb 2014 | PURCHASE | NephroGenex, Inc. | 790,000 | 12.00 USD | |
| 14 Feb 2014 | GRANT_AWARD | NephroGenex, Inc. | 412,592 | — | |
| 14 Feb 2014 | CONVERSION | NephroGenex, Inc. | 890,140 | — | |
| 14 Feb 2014 | CONVERSION | NephroGenex, Inc. | 5,785,962 | — | deriv |
| 14 Feb 2014 | CONVERSION | NephroGenex, Inc. | 13,964,398 | — | deriv |
| 14 Feb 2014 | CONVERSION | NephroGenex, Inc. | — | — | deriv |
| 14 Feb 2014 | CONVERSION | NephroGenex, Inc. | 5,785,962 | — | deriv |
| 02 Jan 2013 | GRANT_AWARD | ACURA PHARMACEUTICALS, INC | 15,000 | — | deriv |
| 03 Jan 2012 | GRANT_AWARD | ACURA PHARMACEUTICALS, INC | 15,000 | — | deriv |
| 25 May 2011 | GRANT_AWARD | Anacor Pharmaceuticals Inc | 15,000 | 0.00 USD | deriv |
| 31 Mar 2011 | GRANT_AWARD | Anacor Pharmaceuticals Inc | 30,000 | 0.00 USD | deriv |
| 03 Jan 2011 | GRANT_AWARD | ACURA PHARMACEUTICALS, INC | 15,000 | — | deriv |
| 30 Nov 2010 | CONVERSION | Anacor Pharmaceuticals Inc | 107,004 | — | |
| 30 Nov 2010 | CONVERSION | Anacor Pharmaceuticals Inc | 1,348,313 | — | |
| 30 Nov 2010 | CONVERSION | Anacor Pharmaceuticals Inc | 102,787 | — | |
| 30 Nov 2010 | CONVERSION | Anacor Pharmaceuticals Inc | 102,787 | 0.00 USD | deriv |
| 30 Nov 2010 | CONVERSION | Anacor Pharmaceuticals Inc | 107,004 | 0.00 USD | deriv |
| 30 Nov 2010 | CONVERSION | Anacor Pharmaceuticals Inc | 1,348,313 | 0.00 USD | deriv |
| 05 Mar 2010 | SALE | ACURA PHARMACEUTICALS, INC | 10,923 | 4.77 USD |